Ignite Creation Date:
2025-12-24 @ 10:08 PM
Ignite Modification Date:
2025-12-28 @ 2:00 AM
Study NCT ID:
NCT05168735
Status:
COMPLETED
Last Update Posted:
2024-08-20
First Post:
2021-12-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ketamine + Mindfulness for Depression
Sponsor:
Rebecca Price
Organization:
Study Overview
Official Title:
Ketamine + Mindfulness for Depression
Status:
COMPLETED
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In this project, the investigators will administer a single infusion of IV ketamine to depressed patients and randomize the patients to receive either a) usual/typical infusion conditions or b) mindfulness training and exercises in conjunction with the infusion. Investigators will test whether the conjunction of ketamine + mindfulness enhances the reductions in depression following a single ketamine infusion.
Detailed Description:
NOTE: The study's target sample size was revised after beginning the study, based on a revised available budget.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?: